ABSTRACT
Objective To evaluate an applicability of lungs magnetic resonance imaging (MRI) in viral pneumonia patients including, but not limited to, COVID-19 in a setting of computed tomography (CT) limited availability.
Methods The study included 11 patients (4 with positive polymerase chain reaction (PCR) test for COVID-19). All of patients underwent an MRI scan of lungs using Single shot fast spin echo (SSFSE), LAVA 3D and IDEAL 3D, EPI Diffusion-weighted imaging (DWI) and Fast Spin Echo (FSE) T2WI without using respiratory or any other trigger. 3 patients also had CT scan.
All scans were analyzed for Ground-glass opacity (GGO) and crazy-paving signs indicating potential viral pneumonia.
Results In 8 (67%) patients foci and zones of slight compaction of the parenchyma were visualized as ‘cloudy sky sign’ on T2WI. GGO zones on CT corresponded to ‘cloudy sky sign’ on MRI in patients who underwent both MRI and CT.
Conclusion Lung MRI allows to identify the signs of viral pneumonia and estimate the severity of the disease and the volume of pulmonary involvement, ‘cloudy sky sign’ on MRI corresponds to GGO in CT. The method could be used in COVID-19 diagnosis. Further research will allow to assess accuracy of MRI compared to CT.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding was received
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data is no available